|To view the regulations for your state, click here|
Presenter: Walter H. Boone, Esq., Balch & Bingham LLP
Alcohol and drug treatment centers save lives. But legal and compliance risk threatens your ability to perform your calling. Ignoring that risk can stunt your growth, put you out of business, or worse, land you in jail. To reduce your legal and compliance risk, you must first know what that risk is. Treatment centers today face legal and compliance risk from many different areas. Assessing and reducing that risk requires a multi-disciplinary approach and expertise in all of the areas where you face risk. Balch & Bingham LLP is a full service law firm uniquely situated to advise treatment centers in all of the areas where they face risk.
Presenter: Pete Nielsen, Chief Executive Officer, CCAPP
Learn about C-CARA's mission to create the nation's first "on demand" addiction treatment system by guaranteeing access to treatment when the individual presents a need and by eradicating waiting lists where Californians die while waiting for treatment. C-CARA's mission will be accomplished through legislative action on a set of legislative bills to address each of the four areas identified as cornerstones of a comprehensive "treatment on demand" system for California.
In recent years, there has been a proliferation of "Florida model" programs in California, even though regulators have emphatically asserted that it is a violation of state law to combine unlicensed sober living with outpatient treatment programs (which are required to be licensed). This webinar answers many questions: What does California law actually say on this matter? What is legal - and, just as important to understand - what is illegal? When is it a problem to integrate unlicensed sober living with outpatient addiction treatment? What are some legislative solutions in the pipeline? Will they likely limit the "Florida model" pattern? Will they offer clarification? The "Florida model" is easily one of the most confusing issues facing program owners and operators anywhere. Like much about running an addiction treatment program or sober living facility, things can appear deceptively simple or straightforward on paper and quickly become convoluted or contradictory in action.
Urine drug testing is one of the hot topics in the addiction treatment industry. There are regulatory compliance issues for laboratories, marketers, and addiction treatment programs. How often can you test urine? Will every test be covered by insurance? In this webinar, find out the latest regulations so your facility is compliant in every aspect of urine drug testing.
You wouldn't be in this industry if you didn't deeply believe that people are capable of surmounting struggles . . . and often, it's the help of caring others that makes all the difference. In the process of assisting your clients on their recovery journey, though, it's crucial that you follow best practices for your facility as a whole so that you run the safest program possible. This webinar is what you need when you're ready to focus on managing health risks in your addiction treatment program.
Perhaps there are no more dreaded words for an owner or operator of an addiction treatment facility than "government investigation." You might be surprised to know that when a facility is the subject of a governmental investigation, often the greatest damage comes not from the investigating body, but (unwittingly and unknowingly) from facility employees themselves. Learn how to prepare your staff (and yourself!) for the event of a government investigation so that the outcome doesn't bring unnecessary harm to your business. We'll cover a wide spectrum of facility-authority interactions, from subpoenas to search warrants and much in between.
The Stone Act (AB 848) provides a critical CPOM exception allowing for intervention overlap in certain medical services. Its very existence acknowledges that, in particular circumstances and for specific reasons, collaboration between physician and treatment program protects the patient more than separation does. But with that said, the Stone Act can be of no use to you or your patients unless you fully understand how and when it excepts the CPOM and how the underlying CPOM is left untouched. And to say these specifics are confusing is an understatement. Some of the webinar's highlights include a look at the remarkable growth of the addiction treatment industry and ensuing patient safety problems, what the CPOM means to you and your program or your practice, the "Rogue Rehabs" perspective, The Stone Act and how it provides for "incidental medical services," and a look at issues ahead as the addiction treatment industry continues to experience inevitable growing pains. Join AATA for this informative webinar.
Insurance companies are increasingly conducting reviews of behavioral health and substance abuse treatment program providers and are looking for cases of fraud and abuse. Their special investigation units are demanding the recoupment of fees paid to such programs based on lack of licensure, certification, and accreditation, questions regarding the appropriateness of claims, and questions regarding the adequacy of documentation for clinical services. What are the key issues insurance companies are raising to demand recoupment of fees from substance abuse treatment programs? What can programs do to prevent such inquiries? Join us for this webinar and you will learn: Recent trends, The Reimbursement Minefield, Practices that Raise the Risk of Claims of Fraud & Abuse, Understanding Insurance Companies' Fraud & Abuse Arguements, Risks Related to the Substance of a Claim, Risks Related to the Billing of a Claim Fraud and Abuse - Payor Concerns, Preauthorization/Verification of Benefits, Billing and Coding Challenges on the Horizon, and Strategies for Reducing Risk.
As group homes proliferated nationally, conflicts arose between property owners concerned over their families’ safety and their property values (“Not In My Back Yard” or “NIMBY”), on one side, and group home operators and disability rights advocates, on the other. Some local governments responded by enacting zoning and other ordinances that restricted, among other things, where and how many group homes could operate in the community and required operators to notify local officials before they opened a home. The “pendulum swing” is highly concerning to many in the industry based on the anticipated constraints and restrictions on growth in a time of insufficient access to meet the need for addiction treatment. It is also destabilizing to operators, investors, and prospective acquirers uncertain about how industry land use regulation is likely to evolve. What are the protections afforded by federal law to small group homes used for the purpose of residential drug rehabilitation? In this webinar you will learn more about recent legislative trends, zoning restrictions, and strategies for the future.
In general, drug treatment programs are licensed and certified as “social model,” non-medical programs and many states prohibit such programs from employing or contracting with doctors. In such states, corporate practice of medicine laws requires health professionals to provide services directly to patients. Drug treatment patients often need medical attention for health issues relating to drug use and mental health treatment for co-occurring disorders. These laws are widely misunderstood, resulting in illegal relationships between treatment programs and physicians as well as unsafe practices. How do addiction treatment facilities operate safely with physician oversight despite the byzantine laws prohibiting them from working with doctors? In this webinar, we will discuss the following: The Scope of Services for Drug & Alcohol Treatment Programs and Licensed Health Professionals, Understanding the Corporate Practice of Medicine and Corporate Structure, Unlicensed Providers and MSOs, PCs and MSOs: What is Allowable, AB848 and Enforcement Issues, How Physicians and Non-Physicians Get Paid, Restrictions on Medical Director Services, and Pre-screening of Patients Before Intake and Documentation.
In this webinar, the following topics will be discussed: The history of residential alcohol and drug rehabilitation programs; The elements of required licensure, certification and accreditation; The “Florida Model” trend for bypassing state licensing requirements by setting up sober living residences in lieu of residential drug rehabs; Regulatory requirements of outpatient programs as compared with sober living facilities; and options for structuring treatment facilities.
Due to the recent surge in investigations of drug treatment program marking and recruiting practices in California. As well as a relaxed history of enforcement, the drug rehab space has developed a liberal culture of paying marketers for patients. Additionally, many young patients in need of addiction treatment do not have insurance and marketers are illegally signing them up for insurance in order to “sell” them to drug rehab facilities. Also, many drug rehabs are utilizing separate nonprofits through which people may donate to buy insurance coverage for patients in need. Insurance companies regard these practices as abusive. What will be covered: What types of financial arrangements are allowed between alcohol and drug treatment programs and marketers? What are the legal ramifications of helping/assisting patients to get insurance in advance of drug treatment? AATA helps addiction treatment professionals to clear their way to compliance.